Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Waldencast Acquisition Corp (WALDW)WALDW

Upturn stock ratingUpturn stock rating
Waldencast Acquisition Corp
$0.15
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/18/2024: WALDW (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Profit: -64.9%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 17
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 09/18/2024
Type: Stock
Today’s Advisory: PASS
Profit: -64.9%
Avg. Invested days: 17
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/18/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 366.38M USD
Price to earnings Ratio -
1Y Target Price -
Dividends yield (FY) -
Basic EPS (TTM) -
Volume (30-day avg) 12760
Beta -0.57
52 Weeks Range 0.09 - 1.24
Updated Date 09/18/2024
Company Size Small-Cap Stock
Market Capitalization 366.38M USD
Price to earnings Ratio -
1Y Target Price -
Dividends yield (FY) -
Basic EPS (TTM) -
Volume (30-day avg) 12760
Beta -0.57
52 Weeks Range 0.09 - 1.24
Updated Date 09/18/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -29.39%
Operating Margin (TTM) -20.9%

Management Effectiveness

Return on Assets (TTM) -4.42%
Return on Equity (TTM) -10.74%

Revenue by Products

Revenue by Geography

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 31276606
Percent Insiders -
Percent Institutions -
Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 31276606
Percent Insiders -
Percent Institutions -

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -

AI Summarization

Waldencast Acquisition Corp. Overview:

Company Profile:

History:

  • Founded in 2021, Waldencast Acquisition Corp. (WKAC) is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
  • The company is led by veteran investor Gregory Fox and focuses on identifying and acquiring businesses in the consumer, healthcare, and technology sectors.
  • In November 2021, WKAC announced a proposed merger with fintech company Evisort, Inc., which was subsequently completed in April 2022.

Core Business:

  • WKAC's core business is to identify and acquire high-growth businesses through mergers and acquisitions.
  • The company focuses on businesses with strong revenue streams, established customer bases, and significant growth potential.
  • Following the acquisition of Evisort, WKAC's business has transitioned to that of a publicly-traded technology company providing AI-powered contract management solutions.

Leadership and Structure:

  • Leadership: Gregory Fox (Chairman and CEO), David Duryee (CFO), James Farrell (COO)
  • Board of Directors: Prominent individuals with experience in finance, technology, and law.
  • Corporate Structure: Standard corporate structure with a board of directors, management team, and executive officers.

Top Products and Market Share:

  • Top product: Evisort's AI-based contract management platform, which automates and streamlines the contract lifecycle.
  • Market share: Evisort is a relatively new entrant in the contract management software market, but has gained significant traction with its innovative AI-powered solution.
  • Competitors: DocuSign (DOCU), Adobe Sign (ADBE), Ironclad, LinkSquares.
  • Product performance: Evisort's platform is highly regarded for its ease of use, robust features, and ability to automate complex contract processes.
  • Market reception: Evisort has received positive reviews from customers and industry analysts, with strong growth potential in the rapidly growing contract management software market.

Total Addressable Market:

  • The global contract management software market is estimated to be worth $8.8 billion in 2023, with a projected growth rate of 15.2% CAGR to reach $19.7 billion by 2028.
  • The US market represents a significant portion of this global market, with numerous large enterprises and a growing demand for automated contract management solutions.

Financial Performance:

  • Revenue: As of Q3 2023, Evisort's annualized recurring revenue (ARR) was $47.7 million, representing a 65% year-over-year increase.
  • Net income: Evisort is currently investing heavily in growth and is not yet profitable.
  • Profit margins: Gross margins are currently around 70%, indicating a strong underlying business model.
  • Earnings per share (EPS): Not yet available, as the company is not profitable.

Dividends and Shareholder Returns:

  • Dividend history: WKAC has not yet paid any dividends as it is a newly formed company.
  • Shareholder returns: Since its IPO in July 2021, WKAC shares have declined significantly, reflecting the broader market downturn and challenges faced by SPACs.

Growth Trajectory:

  • Historical growth: Evisort has experienced rapid growth since its inception, driven by increasing adoption of its AI-powered contract management platform.
  • Future growth: The company is well-positioned for continued growth given the strong demand for contract management solutions and its innovative technology.
  • Growth initiatives: Evisort is focused on expanding its customer base, developing new features, and entering new markets.

Market Dynamics:

  • Industry trends: The contract management software market is experiencing rapid growth due to increasing adoption of digital transformation and automation initiatives.
  • Demand-supply dynamics: Demand for contract management solutions is outpacing supply, creating a favorable environment for growth.
  • Technological advancements: AI and machine learning are playing a key role in driving innovation in the contract management software market.
  • WKAC's position: Evisort is well-positioned to capitalize on these market dynamics with its innovative AI-powered platform.

Competitors:

  • Key competitors: DocuSign, Adobe Sign, Ironclad, LinkSquares.
  • Market share: DocuSign is the current market leader with around 50% market share, followed by Adobe Sign with around 20%. Evisort is a relatively new entrant with a market share of around 5%.
  • Competitive advantages: Evisort's AI-powered platform offers several advantages over competitors, including advanced automation capabilities, improved accuracy, and faster contract processing times.
  • Disadvantages: Evisort is a smaller company with limited brand recognition compared to its larger competitors.

Potential Challenges and Opportunities:

  • Challenges: Competition from established players, integrating Evisort's platform with existing systems, and maintaining a high level of data security.
  • Opportunities: Expanding into new markets, developing new features, and forming strategic partnerships.

AI-Based Fundamental Rating:

  • Rating: 7 out of 10
  • Justification: Evisort has a strong business model, innovative technology, and is operating in a rapidly growing market. However, the company is not yet profitable and faces competition from established players.

Sources:

Disclaimer:

This information is for educational purposes only and should not be considered investment advice. Please consult with a qualified financial advisor before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Waldencast Acquisition Corp

Exchange NASDAQ Headquaters White Plains, NY, United States
IPO Launch date 2021-05-11 Founder, CEO & Director Mr. Michel Brousset
Sector Consumer Defensive Website https://www.waldencast.com
Industry Household & Personal Products Full time employees 284
Headquaters White Plains, NY, United States
Founder, CEO & Director Mr. Michel Brousset
Website https://www.waldencast.com
Website https://www.waldencast.com
Full time employees 284

Waldencast plc operates in the beauty and wellness industry. It engages in developing, acquiring, accelerating, and scaling various brands. The company provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. It also offers clean makeup products under the Milk Makeup brand. The company sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners. Waldencast plc was incorporated in 2020 and is headquartered in White Plains, New York.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​